Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matilde Inglese

Showing results (211-220 of 315) with videos related to

Pageof 32
Sort By:
Neurology|January 19, 2018
Cognition in multiple sclerosis: State of the field and priorities for the futureJames F Sumowski, Ralph Benedict, Christian Enzinger, et al.
European Radiology|March 14, 2022
Stratification of multiple sclerosis patients using unsupervised machine learning: a single-visit MRI-driven approachGiuseppe Pontillo, Simone Penna, Sirio Cocozza, et al.
Neuroimage|October 13, 2018
Depth-dependent intracortical myelin organization in the living human brain determined by in vivo ultra-high field magnetic resonance imagingEmma Sprooten, Rafael O'Halloran, Juliane Dinse, et al.
Plos One|May 27, 2026
Vocational rehabilitation for people with multiple sclerosis: A systematic scoping review of international evidenceCarlotta Gualco, Erica Grange, Federica Rotondi, et al.
Journal of Neurology|June 17, 2021
What happens after fingolimod discontinuation? A multicentre real-life experienceDoriana Landi, Alessio Signori, Maria Cellerino, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 1, 2020
A phase 2 multicenter study of ublituximab, a novel glycoengineered anti-CD20 monoclonal antibody, in patients with relapsing forms of multiple sclerosisEdward Fox, Amy E Lovett-Racke, Matthew Gormley, et al.
Therapeutic Advances in Neurological Disorders|March 5, 2026
Positioning siponimod and the post-treatment gap: the unmet needs of SPMS patients in Italian real-world practiceAurora Zanghì, Giovanna Borriello, Matteo Foschi, et al.
Ebiomedicine|April 15, 2019
Body Mass Index in Multiple Sclerosis modulates ceramide-induced DNA methylation and disease courseKamilah Castro, Achilles Ntranos, Mario Amatruda, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|July 8, 2018
CCR2 on Peripheral Blood CD14<sup>+</sup>CD16<sup>+</sup> Monocytes Correlates with Neuronal Damage, HIV-Associated Neurocognitive Disorders, and Peripheral HIV DNA: reseeding of CNS reservoirs?Mike Veenstra, Desiree A Byrd, Matilde Inglese, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|September 23, 2021
Predictors of Ocrelizumab Effectiveness in Patients with Multiple SclerosisMaria Cellerino, Giacomo Boffa, Caterina Lapucci, et al.
Pageof 32

Showing results (211-220 of 315) with videos related to

Sort By:
Pageof 32
Neurology|January 19, 2018
Cognition in multiple sclerosis: State of the field and priorities for the futureJames F Sumowski, Ralph Benedict, Christian Enzinger, et al.
European Radiology|March 14, 2022
Stratification of multiple sclerosis patients using unsupervised machine learning: a single-visit MRI-driven approachGiuseppe Pontillo, Simone Penna, Sirio Cocozza, et al.
Neuroimage|October 13, 2018
Depth-dependent intracortical myelin organization in the living human brain determined by in vivo ultra-high field magnetic resonance imagingEmma Sprooten, Rafael O'Halloran, Juliane Dinse, et al.
Plos One|May 27, 2026
Vocational rehabilitation for people with multiple sclerosis: A systematic scoping review of international evidenceCarlotta Gualco, Erica Grange, Federica Rotondi, et al.
Journal of Neurology|June 17, 2021
What happens after fingolimod discontinuation? A multicentre real-life experienceDoriana Landi, Alessio Signori, Maria Cellerino, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 1, 2020
A phase 2 multicenter study of ublituximab, a novel glycoengineered anti-CD20 monoclonal antibody, in patients with relapsing forms of multiple sclerosisEdward Fox, Amy E Lovett-Racke, Matthew Gormley, et al.
Therapeutic Advances in Neurological Disorders|March 5, 2026
Positioning siponimod and the post-treatment gap: the unmet needs of SPMS patients in Italian real-world practiceAurora Zanghì, Giovanna Borriello, Matteo Foschi, et al.
Ebiomedicine|April 15, 2019
Body Mass Index in Multiple Sclerosis modulates ceramide-induced DNA methylation and disease courseKamilah Castro, Achilles Ntranos, Mario Amatruda, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|July 8, 2018
CCR2 on Peripheral Blood CD14<sup>+</sup>CD16<sup>+</sup> Monocytes Correlates with Neuronal Damage, HIV-Associated Neurocognitive Disorders, and Peripheral HIV DNA: reseeding of CNS reservoirs?Mike Veenstra, Desiree A Byrd, Matilde Inglese, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|September 23, 2021
Predictors of Ocrelizumab Effectiveness in Patients with Multiple SclerosisMaria Cellerino, Giacomo Boffa, Caterina Lapucci, et al.
Pageof 32